Lisah Burhan
Analyst · Jefferies
Thanks, Sharon, and welcome, everyone. On the call with me today are Benno Dorer, our Chairman and CEO; and Kevin Jacobsen, our CFO. We're broadcasting this call over the Internet and a replay of the call will be available for seven days at our website thecloroxcompany.com. On today's call, we may refer to certain non-GAAP financial measures, including, but not limited to free cash flow, EBIT margin, debt to EBITDA, organic sales growth, and economic profit. Management believes that providing insights on these measures enable investors to better understand and analyze our ongoing results of operations. Reconciliation with the most directly comparable financial measures determined in accordance with GAAP can be found in today's press release, this webcast's prepared remarks, or supplemental information available on our website as well as in our SEC filings. In particular it may be helpful to refer to tables located at the end of today's earnings release. Please also recognize that today's discussion contains forward-looking statements. Actual results or outcomes could differ materially from management's expectations and plans. I would also direct you to read the forward-looking disclaimers in our quarterly earnings release. Please review our most recent 10-K filings with the SEC and our other SEC filings for a description of important factors that could cause results or outcomes to differ materially from management's expectations and plans. The company undertakes no obligation to publicly update or revise any forward-looking statements. I'll start by covering our topline commentary discussing highlights in each of our segments, Kevin will then address our financial results as well as outlook for the fiscal year 2020, and finally, Benno will offer his perspective, and we'll close with Q&A. For the total company, full year sales were up 1%, while Q4 sales decreased 4%, reflecting double-digit sales decline in our Household segment. I'll now go through results by segment. In our Cleaning segment, full year sales grew 2%, while Q4 sales grew 3%, reflecting growth in all three businesses. Our Professional Products business grew sales strongly in FY 2019 wrapping up the year with a double-digit sales growth in Q4. We've introduced a number of innovation platforms in this business over time and they continue to build momentum as we keep expanding distribution in the institutional channel. For example the Clorox Healthcare hydrogen peroxide line which launched in FY 2013; and Clorox Healthcare Fuzion, an FY 2017 innovation both have strong double-digit growth -- double-digit volume growth for the year. In Home Care, sales grew both in Q4 and for the full year. Q4 sales were up behind broad-based volume growth including record quarterly shipments of Clorox Disinfecting Wipes. While early, we're encouraged by the improvement we're seeing in wipes after beginning to address some of the short-term competitive headwinds we discussed in Q3. We'll continue to sharpen our consumer value equation in FY 2020 with an eye on long-term profitable growth for the category and for the brand. We're looking forward to sharing with you an exciting innovation in wipes this fall at our Analyst Day. Lastly, within the Cleaning segment. Our Laundry business sales were up for the quarter and about flat for the full year. We're excited to share that we'll be doing another round of compaction starting in FY 2020 which will drive category growth, while at the same time reducing overall environmental footprint for Clorox Liquid Bleach. While we're pleased with the results we're seeing in three of our four segments this quarter, results in Household were disappointing. Q4 sales were down 11% and full year sales were down 5%, driven mainly by declines in Charcoal and Glad. Turning around these businesses is as a top priority for us and we expect to see improvements in the back half of FY 2020. Now, let's go through the drivers business-by-business. In Charcoal, full year sales declined with Q4 sales down by double-digits due mainly to distribution losses and lower merchandising primarily at two large customers in mass and home hardware during the peak grilling periods in the quarter. We've seen retailers investing more space in support of alternative grilling fuels like lump and pellets, a growth area where we will begin to play in 2020. As a result we experienced lower merchandising support and loss some distribution while competitors have gained. These results are disappointing and we need to launch innovation that allows us to participate in these growing alternative grilling fuel segments and better differentiate Kingsford from competitors. We're working on a stronger 2020 season plan that will include new Kingsford pellets, product improvement across our base Kingsford product, Charcoal, and robust marketing support that will continue to focus on growing household penetration. While we expect the front half of the fiscal to be challenged we believe we'll turn we returned the business to growth in the back half of the fiscal based on the strength of the Kingsford brand, and our expectation that we will significantly improve our business plans for consumers and for retailers. In our Bags and Wraps business, sales were down for the fiscal year with a double-digit decline in Q4. Sales and share declines continued to be driven mainly by wider price gaps as well as distribution losses in select portions of the portfolio, which we've discussed last quarter. In Q3, we began increasing our trade investments to narrow these price gaps, and while it's early, we're starting to see green shoots in select areas where we've seen improvements and shares. Starting this Q1, we're implementing incremental trade investments that will fully close the remaining price gap and that should lead to further improvements on the business. In fiscal year 2020, we're also planning to launch various new products in the fast-growing scented trash bag segment, where Glad has commending equity over competitors. We expect to return to growth by the back half of fiscal year after we cycled through the impact of distribution losses. Longer-term, we continue to feel good about the value creation potential of this business. Our confidence comes from our dedication and significant investment in differentiated consumer and technology-led innovation. For perspective, we filed about 70 patents in the past five years, while our closest branded competitors -- competitor had none. We believe these type of investments will continue to drive long-term profitable growth for the brand and for the category. Turning to RenewLife. Sales were down by double-digits for Q4 and for the year. As we mentioned last quarter, we remain focused on restoring growth in this business and have confidence in the probiotic category and in our ability to differentiate our brand from competition by emphasizing our product efficacy. A continued bright spot in Household segment is our Cat Litter business, where Q4 sales were up on top of double-digit growth in the year ago period mainly due to the benefits of pricing. For the full year, sales were up by double-digits behind additional investment and Fresh Step Clean Paws innovation platform, which offered two new product option in the fiscal year, Mediterranean Lavender scent and unscented. In our Lifestyle segment, sales for the quarter were flat, while sales for the full year were up 17%, primarily reflecting the benefit of Nutranext acquisition. Burt's Bees had a very strong quarter of sales growth behind a record quarterly shipment in lip care and face care and sales were up for the full year as well. Successful innovation in these categories including overnight lips cloves, lip oil and sensitive skin care product continues to drive share growth for the brand. The business has another strong pipeline of innovation plan for FY 2020, including our recently launched lip butters, which offer a trade-up from traditional of lip balms with an experiential form flavor and texture as well as on-trend botanical blend flavors that are relevant to younger consumers. We'll have more to share with you on this in October. As we mark the one-year anniversary of our acquisition of Nutranext, sales were up for the quarter driven by strong growth in our strategic brands, which represents about 80% of the portfolio. We continue to be pleased with the progress we've made on this business, including the integration and of high expectation for FY 2020. Food sales were flat for the quarter, but up for the year. Q4 results reflect continued strength in bottled Hidden Valley dressing offset by lower shipments in Dry Hidden Valley products, which had double-digit growth in the year ago quarter. Ready-to-eat dips are off to a good start with early indications that the innovation is expanding usage occasions for the brand. Overall, the brand remains healthy and enjoyed its 18th consecutive quarter of share growth. Wrapping up the Lifestyle segment. Brita sales were down for the quarter, while being up for the full year. The Q4 sales decline was driven by timing of trade spending. This benefited Q3 sales, which were up by high single-digits, while drawing from this quarter. Importantly, this business is healthy as reflected by a solid and consistent volume growth in all four quarters of FY 2019. Consumption has continued to grow for eight consecutive quarters, and we're pleased to see our tracked channel market share up nearly one point in the last 13 weeks. We're also excited by the strong start of our bottle innovation, which was supported to increase demand spending. Finally, turning to International. Sales decreased 4% in Q4, driven by about 15 points of unfavorable foreign currency impact primarily in Argentina, which were partially offset by the benefits of price increases and volume growth. Europe and China both recorded double-digit volume growth for the quarter behind the strong performance of Cat Litter and Burt's Bees. Sales were down 6% for the full year, reflecting 15 points of headwinds from foreign currency impact. At the same time, we're pleased to see solid sales growth in a number of markets. With that, I'll turn it over to Kevin, who will discuss our Q4 and fiscal year financial performance as well as outlook for fiscal year 2020.